陳振光，男，主任醫師，心胸外科主任，醫學博士，兼任廣東省醫院協會腫瘤防治管理分會大會秘書長，廣東省醫院協會腫瘤防治管理分會胸部腫瘤專業委員會副主任委員，廣州東部醫學論壇秘書長，歐洲臨床腫瘤學會 (ESMO) 會員，中國醫師協會胸外科分會委員，廣州市醫學會中青年學術研究會委員，廣東省醫學會胸心血管外科學會會員，國家自然科學基金評審專家，《中國組織工程與臨床康復雜志》執行編委，Chinese Med J-Peking、Thorac Cancer、J Cardiothorac Surg、Clinical Medical Insights: Oncology等雜志的評審專家。主要研究方向為肺癌的分子發病機制和治療以及重癥肌無力的外科治療，獲得包括國家自然科學基金和廣東省科技攻關項目等多項課題，已發表論文40余篇，其中SCI索引雜志論文多篇，并曾在2010年第二屆歐洲肺癌大會（2nd European Lung Cancer Conference）發言，影響因子累積近30分。 已發表論文： 1、Chen Z, Wang T, Luo H, et al. Expression of nestin regarding to lymph node metastasis and lymphangiogenesis in non-small cell lung cancer patients. Human Pathology 2010, 41: 737-744. 2、Chen Z，Wang T, Cai L, et al. Clinicopathological significance of non-small cell lung cancer with high prevalence of Oct-4 tumor cells. J Clin Exp Res 2012, 31: 10. 3、Su C, Chen Z (Correspondence author)，Luo H, et al. Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinoma. J Clin Exp Res 2011, 30: 85. 4、Luo H, Chen Z (Correspondence author), Jin H, et al. Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer. J Exp Clin Cancer Res 2011, Jan10; 30(1): 6. 5、Chen Z，Wang T, Luo H, et al. Nestin expression in non-small cell lung cancer and its relevance with prognostic significance. J Thoracic Oncology 2010, 5(Suppl 1): S39. 6、Chen Z, Luo H, Peng Y, et al. Comparative clinical features and immune responses after extended thymectomy for myasthenia gravis in patients with atrophic versus hyperplastic thymus. Ann Thorac Surg 2011, Jan; 91(1): 212-8. 7、Chen Z，Pan H, Tao Wang, et al. Primary thymic seminoma in a 32-year-old female. Ann Oncology 2010, May; 21(5): 1132-4. 8、Chen Z, Luo H, Zhuang M, et al. Effects of ischemic preconditioning on ischemia/reperfusion-induced arrhythmias by upregulatation of connexin 43 expression. J Cardiothorac Surg 2011; 6:80. 9、Luo H, Lei Y, Chen Z (Correspondence author), ...

熟悉胸外科常見病的診治包括：⑴電視胸腔鏡；⑵肺癌診斷、微創切除、化療和靶向治療、免疫治療，各類肺葉切除，支氣管擴張，肺大庖和自發性氣胸；⑶胸腺瘤與重癥肌無力的外科治療、藥物治療；⑷食管癌診斷、根治性切除和化療、食管狹窄、賁門失弛緩癥；⑸縱隔腫瘤切除；⑹漏斗胸微創矯治；⑺肺氣腫微創肺減容；（8）肺移植等。